Legislation Would Create Medicare Service For Comprehensive Cancer Care planning.
Bill Would Improve Quality Of Care, Close Gaps in Services, Supporters Say. Sen. Arlen Specter to NIH Advocates: “Be More Politically Active;” Asks NCI For “A Winning Strategy.”
Group Opposes Bill To Allow Drug Sales After Phase I.
FDA Encourages Randomized Trials For Medical Devices.
NCI Begins TAILORx Study.
Trending Stories
- Oncologist Rachna Shroff endows award to outlast her cancer diagnosis
“Because of my health, I have a profound desire to see this endowment come to fruition now” - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Letai: MCEDs are a “great ideal”—alas, the data don’t support widespread use
“Projecting sub-ideal tests across a large population can cause harm,” Letai says, as Galleri cruises toward FDA approval - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - As FDA sidesteps the question of Galleri’s clinical benefit, NCI’s Letai has “some concerns”
- Cancer vaccine policy in limbo as CDC keeps canceling advisory meetings









